Abiopharma

MINDMAZE THERAPEUTICS HOLDING SA (RLFTY)

Symbol	RLFTY
Name	MINDMAZE THERAPEUTICS HOLDING SA
Sector	UNDEFINED
Region	Europe
Industry	-
Address	1202 Switzerland Avenue de Secheron 15
Telephone	+41 22 545 11 16
Fax	—
Email	—
Website	https://mindmazetherapeutics.com/
Incorporation	CH
Incorporated On	2009
Employees	—
Fiscal Year	12/31
Public Since	—
Exchanges	OTC
Auditor	Forvis Mazars, LLP;
Audit Status	AUDITED
Reporting Status	International Reporting: SIX Swiss Exchange
CIK	0001854078
Description	MindMaze Therapeutics Holding SA is a Swiss commercial-stage company developing and commercializing digital neurotherapeutics for neurological diseases. Its clinically validated platform supports treatments for stroke, Parkinsons, and cognitive decline, while advancing R&D in additional brain disorders. The Company also manages a portfolio of rare disease biopharmaceutical assets. Additional info from OTC: MindMaze Therapeutics Holding SA is a Swiss commercial-stage company developing and commercializing digital neurotherapeutics for neurological diseases. Its clinically validated platform supports treatments for stroke, Parkinsons, and cognitive decline, while advancing R&D in additional brain disorders. The Company also manages a portfolio of rare disease biopharmaceutical assets.

2025-03-27 20:30

New Form F-6 POS - Relief Therapeutics Holding SA Filed: 2025-03-27 AccNo: 0001161697-25-000121 Size: 385 KB

2024-12-17 22:20

New Form 424B3 - Relief Therapeutics Holding SA Filed: 2024-12-17 AccNo: 0001161697-24-000521 Size: 129 KB

2024-12-17 21:55

New Form 15F-12G - Relief Therapeutics Holding SA Filed: 2024-12-17 AccNo: 0001161697-24-000517 Size: 23 KB

2024-12-16 21:30

(99% Neutral) RELIEF THERAPEUTICS HLDG AG (RLFTF) Announces Clinical Development Update (Form 6-K)

2024-11-05 21:53

New Form 6-K - Relief Therapeutics Holding SA Filed: 2024-11-05 AccNo: 0001161697-24-000431 Size: 44 KB

2024-10-28 20:58

(80% Positive) RELIEF THERAPEUTICS HLDG AG (RLFTF) Announces Clinical Development Update (Form 6-K)

2024-10-22 21:31

(80% Positive) RELIEF THERAPEUTICS HLDG AG (RLFTF) Announces Clinical Development Update (Form 6-K)

2024-10-09 20:31

(80% Positive) RELIEF THERAPEUTICS HLDG AG (RLFTF) Announces Clinical Development Update (Form 6-K)

2024-09-23 20:30

(90% Positive) RELIEF THERAPEUTICS HLDG AG (RLFTF) Announces Clinical Development Update (Form 6-K)

2024-08-31 18:11

OTCQB symbol attribute type Security_Name was changed. Previous value: -. New value: RELIEF THERAPEUTICS HLDG.